Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | MMP14 | P50281 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31532309 | 1.00 | CD44 (0.44) | CD44GAAALDH1A1MAPTKDM4E | |
| Hydrochloric Acid SCHEMBL3843541 | 0.98 | ALDH1A1 (0.44) | CD44GAAALDH1A1MAPTKDM4E | |
| Hydrochloric Acid SCHEMBL8223051 | 0.86 | ACHE (0.43) | CD44GAAALDH1A1MAPTKDM4E | |
| SCHEMBL6065571 | 0.82 | HSD17B10 (0.46) | CD44GAAALDH1A1MAPTKDM4E | |
| SCHEMBL17744621 | 0.78 | CD44 (0.41) | CD44GAAALDH1A1MAPTKDM4E | |
| SCHEMBL10771021 | 0.78 | HSD17B10 (0.59) | GAAALDH1A1MAPTKDM4ELMNA | |
| SCHEMBL11155205 | 0.78 | HSD17B10 (0.59) | CD44GAAALDH1A1MAPTKDM4E | |
| SCHEMBL7023508 | 0.76 | HSD17B10 (0.44) | GAAALDH1A1MAPTLMNAHPGD | |
| SCHEMBL157575 | 0.76 | CYP3A4 (0.44) | GAAALDH1A1MAPTKDM4ELMNA | |
| SCHEMBL5526674 | 0.75 | THRB (0.46) | GAAALDH1A1MAPTKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10639257-B2 | Composition for colouring keratin fibres | BEAUTY & BUSINESS S.P.A. (IT) | 2020-05-05 | — | — | US | claimed |
| US-20190117541-A1 | COMPOSITION FOR COLOURING KERATIN FIBRES | BEAUTY & BUSINESS S.P.A. (IT) | 2019-04-25 | — | — | US | claimed |
| US-9993413-B2 | Keratin fibre dyeing composition | BEAUTY & BUSINESS S.P.A. (IT) | 2018-06-12 | — | — | US | claimed |
| US-20170258695-A1 | KERATIN FIBRE DYEING COMPOSITION | BEAUTY & BUSINESS S.P.A. (IT) | 2017-09-14 | — | — | US | claimed |
| WO-2015104713-A1 | COLORING COMPOSITIONS AND METHODS | Ramot at Tel- Aviv University Ltd. (IL) | 2015-07-16 | — | — | WO | claimed |
| US-20110065760-A1 | COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF | JERINI AG (DE) | 2011-03-17 | — | — | US | claimed |
| US-7652089-B2 | Nanocomposite, nanocomposite electrolyte membrane and fuel using the same | SAMSUNG SDI CO., LTD. (KR) | 2010-01-26 | — | — | US | claimed |
| EP-2100876-A2 | New compounds for the inhibition of rotamases and use thereof | Jerini AG (DE) | 2009-09-16 | — | — | EP | claimed |
| US-20080176126-A1 | ELECTROLYTE MEMBRANE COMPRISING NANOCOMPOSITE ION COMPLEX, MANUFACTURING METHOD THEREOF, AND FUEL CELL INCLUDING THE SAME | SAMSUNG SDI CO, LTD. (KR) | 2008-07-24 | — | — | US | claimed |
| US-20070072982-A1 | Nanocomposite, nanocomposite electrolyte membrane and fuel using the same | SAMSUNG SDI CO., LTD. (KR) | 2007-03-29 | — | — | US | claimed |
| EP-1539683-A2 | PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS | Jerini AG (DE) | 2005-06-15 | — | — | EP | claimed |
| EP-1066269-B1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2005-05-11 | — | — | EP | claimed |
| WO-2004030664-A2 | NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF | JERINI AG (DE) | 2004-04-15 | — | — | WO | claimed |
| WO-2004026815-A2 | PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS | JERINI AG (DE) | 2004-04-01 | — | — | WO | claimed |
| EP-1402887-A1 | New compounds for the inhibition of undesired cell proliferation and use thereof | Jerini AG (DE) | 2004-03-31 | — | — | EP | claimed |
| EP-1402888-A1 | The use of substituted carbocyclic compounds as rotamases inhibitors | Jerini AG (DE) | 2004-03-31 | — | — | EP | claimed |
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | DAEYAERT FREDERIK FRANS DESIRE (BE) | 2002-08-22 | — | — | US | claimed |
| EP-1066269-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-01-10 | — | — | EP | claimed |
| US-6150360-A | ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-11-21 | — | — | US | claimed |
| WO-1999050256-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-10-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | XDH, CCR5, CXCR1 | CD44 4839/4885GAA 4227/4885ALDH1A1 3722/4885 |
| US-20110065760-A1 | COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF | NR1I3, NR1D1, NR1D2 | CD44 3264/4885GAA 4010/4885ALDH1A1 2565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.